Y-mAbs Announces First Quarter Financial Results and Recent Corporate Developments 09 May 2022
NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more
NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more
May 2, 2022, LINK Medical and Serendipity Partners announce a new partnership. Serendipity Partners (Serendipity)... Read more
The SDG Business Accelerator is driven by the Ministry of Foreign affairs in partnership with a number... Read more
NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more
Available to researchers and students at Danish research institutions for exploring opportunities for... Read more
The Danish biotech company Cysbio may have broken the code on how to eliminate copper in... Read more
Biotech – a rapid growth journey While accelerated by the pandemic, biotech was already on a rapid... Read more
Press Release PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s year-end report for... Read more
I forbindelse med life science-strategien er det besluttet, at der skal foretages en analyse af forskningsbaserede... Read more